Main Content
Dan Shu, PhD
Dr. Shu has devoted her research career to the development of RNA nanotechnology for the treatment of cancers, specifically focusing on the treatment of breast cancer, including triple negative breast cancer. Dr. Shu is developing novel therapeutics utilizing RNA nanoparticles for the specific delivery of small interfering miRNA or siRNA to cancers and related stem cells. Her long-term objective is to focus on the development and translation of RNA nanotechnology-based therapeutics and imaging agents into clinical trials.